Hannah Valantine
CIK: 0001855608
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Jul 16, 2026CDNA
CareDx, Inc.
Exercise(M)Direct7.6K shares at avg. $20.56$156K - Jul 16, 2026CDNA
CareDx, Inc.
Sale(S)Direct100 shares at avg. $36.55$4K - Jul 16, 2026CDNA
CareDx, Inc.
Sale(S)Direct28.7K shares at avg. $36.14$1.0M - Jul 16, 2026CDNA
CareDx, Inc.
Exercise(M)Direct5.1K shares at avg. $7.96$41K - Jul 16, 2026CDNA
CareDx, Inc.
Exercise(M)Direct16K shares at avg. $14.19$228K - Jun 23, 2026BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct2.2K shares at avg. $68.57$151K - Jun 22, 2026BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct2.8K shares at avg. $68.00$191K - Jun 22, 2026BBIO
BridgeBio Pharma, Inc.
Exercise(M)Direct2.8K shares at avg. $41.73$117K - Jun 22, 2026BBIO
BridgeBio Pharma, Inc.
Award(A)Direct4K shares- - Jun 15, 2026CDNA
CareDx, Inc.
Sale(S)Direct12.1K shares at avg. $23.11$280K - Jun 12, 2026CDNA
CareDx, Inc.
Award(A)Direct9.8K shares- - Jun 3, 2026PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Award(A)DirectStock Option (right to buy)
223.5K shares- - Mar 10, 2026BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct8.7K shares at avg. $72.00$624K - Mar 10, 2026BBIO
BridgeBio Pharma, Inc.
Exercise(M)Direct8.7K shares at avg. $27.36$237K - Feb 27, 2026BBIO
BridgeBio Pharma, Inc.
Exercise(M)Direct25.5K shares at avg. $48.45$1.2M - Feb 27, 2026BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct10.9K shares at avg. $67.84$739K - Feb 27, 2026BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct14.6K shares at avg. $67.08$978K - Nov 12, 2025BBIO
BridgeBio Pharma, Inc.
Exercise(M)Direct25.5K shares at avg. $48.45$1.2M - Nov 12, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct25.5K shares at avg. $66.07$1.7M - Jun 26, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct1.5K shares at avg. $44.01$68K - Jun 26, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct876 shares at avg. $44.11$39K - Jun 26, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Indirect1.9K shares at avg. $44.03$83K - Jun 26, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Indirect398 shares at avg. $44.13$18K - Jun 20, 2025BBIO
BridgeBio Pharma, Inc.
Award(A)Direct6.6K shares- - Jun 18, 2025CDNA
CareDx, Inc.
Sale(S)Direct10.6K shares at avg. $19.16$203K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 |  CDNA CareDx, Inc. | Exercise(M) | 7,606 | $20.56 | $156,379 | Direct |
| Jul 16, 2026 | CDNA CareDx, Inc. | Sale(S) | 100 | $36.55 | $3,655 | Direct |
| Jul 16, 2026 | CDNA CareDx, Inc. | Sale(S) | 28,679 | $36.14 | $1,036,588 | Direct |
| Jul 16, 2026 | CDNA CareDx, Inc. | Exercise(M) | 5,125 | $7.96 | $40,795 | Direct |
| Jul 16, 2026 | CDNA CareDx, Inc. | Exercise(M) | 16,048 | $14.19 | $227,721 | Direct |
| Jun 23, 2026 |  BBIO BridgeBio Pharma, Inc. | Sale(S) | 2,196 | $68.57 | $150,580 | Direct |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 2,808 | $68.00 | $190,944 | Direct |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise(M) | 2,808 | $41.73 | $117,178 | Direct |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc. | Award(A) | 3,990 | - | $0 | Direct |
| Jun 15, 2026 | CDNA CareDx, Inc. | Sale(S) | 12,103 | $23.11 | $279,728 | Direct |
| Jun 12, 2026 | CDNA CareDx, Inc. | Award(A) | 9,795 | - | $0 | Direct |
| Jun 3, 2026 |  PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Award(A) Stock Option (right to buy) | 223,492 | - | - | Direct |
| Mar 10, 2026 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 8,671 | $72.00 | $624,312 | Direct |
| Mar 10, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise(M) | 8,671 | $27.36 | $237,239 | Direct |
| Feb 27, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise(M) | 25,484 | $48.45 | $1,234,700 | Direct |
| Feb 27, 2026 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 10,900 | $67.84 | $739,496 | Direct |
| Feb 27, 2026 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 14,584 | $67.08 | $978,285 | Direct |
| Nov 12, 2025 | BBIO BridgeBio Pharma, Inc. | Exercise(M) | 25,484 | $48.45 | $1,234,700 | Direct |
| Nov 12, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 25,484 | $66.07 | $1,683,728 | Direct |
| Jun 26, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 1,542 | $44.01 | $67,863 | Direct |
| Jun 26, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 876 | $44.11 | $38,640 | Direct |
| Jun 26, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 1,891 | $44.03 | $83,261 | Indirect |
| Jun 26, 2025 | BBIO BridgeBio Pharma, Inc. | Sale(S) | 398 | $44.13 | $17,562 | Indirect |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | Award(A) | 6,589 | - | - | Direct |
| Jun 18, 2025 | CDNA CareDx, Inc. | Sale(S) | 10,570 | $19.16 | $202,566 | Direct |
1-25 of 34 transactions
About Valantine Hannah
Valantine Hannah (SEC CIK 0001855608) files insider reports with the SEC as Director of CareDx, Inc. (CDNA), Director of BridgeBio Pharma, Inc. (BBIO) and Director of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).
Signal8 holds 16 ownership filings by Valantine Hannah, all Form 4s, filed between Mar 10, 2025 and Jul 17, 2026. Those filings report 34 transactions, from Dec 28, 2021 to Jul 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Valantine Hannah's filings is in BRISBANE, CA.
Recent filings by Valantine Hannah
- Jul 16, 2026: Option exercise of CDNA shares (Form 4, code M).
- Jul 16, 2026: Open-market sales of CDNA shares (2 lines, Form 4, code S).
- Jul 16, 2026: Option exercises of CDNA shares (2 lines, Form 4, code M).
- Jun 23, 2026: Open-market sale of BBIO shares (Form 4, code S).
- Jun 22, 2026: Open-market sale of BBIO shares (Form 4, code S).
Other insiders filing for CareDx, Inc. (CDNA)
- Novack Jeffrey Adam, Secretary and General Counsel
- Hanna John Walter JR, President and CEO
- Kennedy Keith, CFO & COO
- Meng Jessica, Chief Commercial Officer
- Goldberg Michael, Director
- Bickerstaff George, Director